Skip to main content


  • Case report
  • Open Access
  • Open Peer Review

Esophageal squamous cell carcinoma presenting with extensive skin lesions: a case report

  • 1Email author,
  • 1,
  • 1,
  • 1,
  • 2,
  • 1 and
  • 1
Journal of Medical Case Reports20082:115

  • Received: 26 September 2007
  • Accepted: 21 April 2008
  • Published:
Open Peer Review reports



Esophageal squamous cell carcinoma (ESCC) is the most common histological subtype of cancer in the upper and middle esophagus and is characterized by a high rate of mortality. The incidence of esophageal cancer varies greatly among regions of the world and occurs at a high frequency in Asia and South America.

Case presentation

In our department, a 51-year-old man was diagnosed with ESCC after presenting with extensive disseminated skin nodules. Biopsy of the nodules showed metastatic ESCC. Cutaneous manifestations of esophageal neoplasia are very rare and are mainly described for esophageal adenocarcinoma (EADC). Here we report a very uncommon case of extensive skin metastases of ESCC.


Early biopsies of suspicious skin lesions are important and should be performed in patients with unclear symptoms such as weight loss or dysphagia and especially in patients with a history of cancer, since they can reveal the existence of a distant malignant disease leading to diagnosis and prompt therapy.


  • Esophageal Cancer
  • Esophageal Squamous Cell Carcinoma
  • Esophageal Carcinoma
  • Esophageal Adenocarcinoma
  • Cutaneous Metastasis


Cancer of the esophagus is the ninth most common malignancy and ranks as the sixth most frequent cause of cancer death in the world, constituting 7% of all gastrointestinal cancers [1]. Patients with esophageal cancer usually present with disease that is locally advanced and which has already metastasized stage at the time of initial diagnosis. Cancer of the esophagus exists in two main forms with different etiological and pathological characteristics: esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EADC). ESCC is the predominant histological subtype, comprising about 70% of cases [2].

In general, skin metastases from malignant tumors of the internal organs are rarely seen, with a frequency of between 0.7 and 9% [35]. The overall survival rate varies from 4.3 to 4.7 months [6]. The cancer types most commonly associated with cutaneous metastases are breast, lung and melanoma [4, 7, 8]. Metastatic spread to the skin occurs either hematogenously or via the lymphatic system and presents in the form of rapidly growing papules or nodules [9, 10]. On histopathology, clusters of atypical cells infiltrating the dermis without connection to the adjacent epidermis can be seen [6]. Here we report an uncommon case of massive cutaneous metastases of ESCC in a 51-year-old man.

Case presentation

A 51-year-old man was admitted to our department with a four-week history of dysphagia, weight loss and nausea. He had a medical history of multiple sclerosis since April 2004 and a smoking history of 30 pack-years. The patient underwent esophagogastroduodenoscopy resulting in the diagnosis of esophageal carcinoma located in the mid-thoracic part of the esophagus. Histology of an endosonography-guided biopsy showed an intermediate grade ESCC according to the criteria of the American Joint Committee of Cancer (AJCC). Moreover, the patient presented with approximately 20 diffuse, painless and solid skin nodules that were about 1–3 cm in diameter, found all over his body surface including the scalp, upper extremities, axillae, back, chest and abdominal wall. According to the patient they had been growing rapidly over the previous four weeks, and he had noticed the first skin lesion more than two months earlier. Excisional biopsy of one representative prominent cutaneous formation on the abdominal wall was performed. On macroscopic inspection, the lesion was superficially ulcerated and measured 2 cm × 3 cm (Figure 1). Histopathology revealed nodulous skin infiltration of intermediate grade ESCC (Figure 2). Interestingly, staging by thoracoabdominal computed tomography (CT) scan showed some of these skin lesions (Figure 3). Extensive mediastinal lymph nodes and multiple osteolytic lesions of the spine were also detected without signs of any other tumor manifestation (T1-2, N1, M1, G2; ESCC state IV). The patient subsequently received palliative chemotherapy with cisplatin (80 mg/sqm) and 5-fluoruracil (1,000 mg/sqm) given over four days every three weeks. After three cycles of chemotherapy, the cutaneous metastases became smaller, but some appeared in new areas.
Figure 1
Figure 1

Representative ESCC skin metastasis on the abdominal wall Diameter 2–3 cm.

Figure 2
Figure 2

Histopathology. Infiltration of cutis and subcutaneous fat by intermediate grade atypical squamous cell clusters (HE).

Figure 3
Figure 3

Thoraco-abdominal CT scan showing two representative cutaneous metastases (arrows).


Due to the extreme rarity of cutaneous metastases from ESCC, there are only limited data in the literature regarding their incidence. Fereidooni and colleagues reported a solid facial skin metastasis of EACC [11]. Two additional cases have been published discussing solitary metastases on a digit from an unusual variant of ESCC, the basaloid squamous cell carcinoma [12, 13]. Schoenlaub and colleagues reviewed the clinical findings and overall survival of 200 patients with cutaneous metastases of various cancers. The incidence of cutaneous metastases from EACC was 2 out of the 200 cases studied [6]. The cancers most frequently causing cutaneous metastases were breast cancers (n = 64), pulmonary cancers (n = 36) and melanomas (n = 31) [6]. Reingold reported clinical and necropsy findings of 32 cases out of 2,300 internal carcinomas. The most common primary site was the lungs (50%). The esophagus was the primary tumor site in just one case and this was an adenocarcinoma. The most common sites of skin metastases were on the chest and abdomen [14]. Lookingbill et al reviewed 420 patients with cutaneous metastases from melanoma and carcinoma [9]. In this study, tumor registry data from 7,608 patients was evaluated; 4,020 of these patients had metastatic disease and 420 (10.4%) had cutaneous metastases. The most common primary tumors causing cutaneous metastases were melanoma (n = 77) and breast cancer (n = 212). The esophagus was the primary site in only three cases, spreading mainly to the chest and abdomen [9]. Tharakaram described five cases of skin metastases from ESCC in male patients [15].


Skin manifestations of ESCC are extremely rare and only a small number of cases with solid skin metastases have been reported. A case of ESCC with such diffuse and massive skin metastases, most likely indicating highly aggressive disease, has not been described previously. Our patient complained about these unusual cutaneous metastases before any of the more usual symptoms such as dysphagia or weight loss were manifested.




We thank A Niendorf MD and K Hamper MD for providing histopathological figures, T Göttsche MD for radiological diagnosis and HANSERAD for providing the CT scan pictures.

Authors’ Affiliations

Department of Internal Medicine, Oncology and Hematology, University Hospital Hamburg, Eppendorf, Martinistrasse, 20246, Hamburg, Germany
Department of Internal Medicine, Bethesda Hospital, Hamburg, Germany


  1. Levine MS, Halvorsen RA: Carcinoma of the esophagus. Textbook of Gastrointestinal Radiology. Edited by: Gore RM, Levine MS. 2000, Philadelphia, PA: Saunders, 403-433.Google Scholar
  2. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001, 94: 153-156. 10.1002/ijc.1440.View ArticlePubMedGoogle Scholar
  3. Spencer PS, Helm TN: Skin metastases in cancer patients. Cutis. 1987, 39: 119-121.PubMedGoogle Scholar
  4. Lookingbill DP, Spangler N, Sexton FM: Skin involvement as the presenting sign of internal carcinoma. J Am Acad Dermatol. 1990, 22: 19-26.View ArticlePubMedGoogle Scholar
  5. Rosen T: Cutaneous metastases. Med Clin North Am. 1980, 64: 885-900.View ArticlePubMedGoogle Scholar
  6. Schoenlaub P, Sarraux A, Grosshans E, Heid E, Cribier B: Survival after the occurrence of cutaneous metastasis: a study of 200 cases. Ann Dermatol Venereol. 2001, 128: 1310-1315.PubMedGoogle Scholar
  7. Brownstein MH, Helwig EB: Patterns of cutaneous metastasis. Arch Dermatol. 1972, 105: 862-868. 10.1001/archderm.105.6.862.View ArticlePubMedGoogle Scholar
  8. Schoenlaub P, Meyer P, Heid E, Grosshans E, Cribier B: Métastases cutanées révélatrices d'un cancer méconnu. Étude anatomoclinique de 40 cas. Ann Dermatol Venereol. 1998, 3S: 90-91.Google Scholar
  9. Lookingbill DP, Spangler N, Helm KF: Cutaneous metastases in patients with metastatic carcinoma: A retrospective study of 4020 patients. J Am Acad Dermatol. 1993, 29: 228-236.View ArticlePubMedGoogle Scholar
  10. Schwartz RA: Cutaneous metastatic disease. J Am Acad Dermatol. 1995, 31: 161-182. 10.1016/0190-9622(95)90231-7.View ArticleGoogle Scholar
  11. Fereidooni F, Kovacs K, Azizi MR, Nikoo M: Skin metastasis from an occult esophageal adenocarcinoma. Can J Gastroenterol. 2005, 19: 673-676.View ArticlePubMedGoogle Scholar
  12. Houston JD, Telepak RJ: An isolated digital metastasis of esophageal basaloid squamous cell carcinoma. Clin Nucl Med. 2000, 25: 557-558. 10.1097/00003072-200007000-00018.View ArticlePubMedGoogle Scholar
  13. Silfen R, Amir A, Tobar A, Hauben DJ: The digital pulp as a presenting site of metastatic esophageal carcinoma. Ann Plast Surg. 2001, 46: 183-184. 10.1097/00000637-200102000-00019.View ArticlePubMedGoogle Scholar
  14. Reingold IM: Cutaneous metastases from internal carcinoma. Cancer. 1966, 19: 162-168. 10.1002/1097-0142(196602)19:2<162::AID-CNCR2820190204>3.0.CO;2-A.View ArticlePubMedGoogle Scholar
  15. Tharakaram S: Metastases to the skin. Int J Dermatol. 1988, 27: 240-242. 10.1111/j.1365-4362.1988.tb03216.x.View ArticlePubMedGoogle Scholar


© Iwanski et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.